Nocturnal hemodialysis significantly improves the ability of early-outgrowth endothelial progenitor-like cells (EPLCs) to promote the growth of new blood vessels and thus restore perfusion in a model of ischemic vascular disease, according to findings published in the Clinical Journal of the American Society of Nephrology (2011;6:1345-1353).
When EPLCs from conventional dialysis patients, nocturnal patients, and healthy controls were injected into rats, the latter two sets of cells significantly improved ischemic hindlimb perfusion and capillary density.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.